PAI-1 is an important inhibitor of the fibrinolysis system, so high levels of this molecule may suppress the degradation process of plasminogen to form plasmin by inhibition of urikinase, representing a significant risk factor for macro-vascular complications and cardiovascular disease, particularly in patients with diabetes. This evidence concerns the gene SERPINE1 and cardiovascular disorder.